Related Experiment Video

Updated: Feb 17, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K

MicroRNA-582-5p suppressed gastric cancer cell proliferation via targeting AKT3

Y Jin1, L-P Tao, S-C Yao

  • 1Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Xinyuan District, Wenzhou, Zhejiang Province, China. 79661623@qq.com.

European Review for Medical and Pharmacological Sciences
|December 12, 2017
PubMed
Abstract

Insights

MicroRNA-582-5p (miR-582-5p) acts as a tumor suppressor in gastric cancer by inhibiting cell growth and promoting apoptosis. It targets AKT3, offering a potential therapeutic strategy for gastric cancer treatment.

Area of Science:

  • Molecular Oncology
  • Cancer Biology
  • Biochemistry

Background:

  • Gastric cancer remains a significant global health challenge.
  • Understanding the molecular mechanisms underlying gastric cancer progression is crucial for developing effective therapies.
  • MicroRNAs (miRNAs) play critical roles in various cancers, including gastric cancer.

Purpose of the Study:

  • To elucidate the functional role of miR-582-5p in gastric cancer cell growth.
  • To identify potential therapeutic targets for gastric cancer treatment based on miR-582-5p function.

Main Methods:

  • Quantitative Real-time PCR (qRT-PCR) to measure miR-582-5p expression.
  • Cell counting kit-8 (CCK8) and colony formation assays for proliferation and viability.
  • Flow cytometry for apoptosis and cell cycle analysis.
  • Luciferase and Western blotting assays to validate target genes.

Main Results:

  • MiR-582-5p was significantly downregulated in gastric cancer tissues compared to adjacent normal tissues.
  • Overexpression of miR-582-5p suppressed gastric cancer cell proliferation and viability.
  • Upregulating miR-582-5p induced apoptosis and caused cell cycle arrest at the G0/G1 phase.
  • AKT3 was identified as a direct target of miR-582-5p, and its restoration counteracted the tumor-suppressive effects of miR-582-5p.

Conclusions:

  • MiR-582-5p exhibits tumor-suppressive properties in gastric cancer by targeting AKT3.
  • This miRNA represents a promising candidate for the diagnosis and treatment of gastric cancer.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K